Work

EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma

Year: 2019

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-19-2549

Authors: Shaofang Wu, Feng Gao, Siyuan Zheng, Chen Zhang, Emmanuel Martinez-Ledesma, Ravesanker Ezhilarasan, Jie Ding, Xiaolong Li, Ningping Feng, Asha Multani, Erik P. Sulman, Roel G. Verhaak, John F. de Groot, Tim P. Heffernan, W.K. Alfred Yung, Dimpy Koul

Institutions: The University of Texas MD Anderson Cancer Center, Tecnológico de Monterrey

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Foundation for Cancer Research

Award: G3788496842

OpenAlex ID: W2996525046

FWCI: 1.541

Cites: 49

Cited by: 51

Related to: 10